PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance

  • Michèle Guerre-Millo
    Unit 465, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
  • Christine Rouault
    Unit 341, INSERM, Hôtel-Dieu, Paris, France
  • Philippe Poulain
    Unit 545, INSERM, Département d’Athérosclérose, Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France
  • Jocelyne André
    Unit 465, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
  • Vincent Poitout
    Pacific Northwest Research Institute and the Department of Medicine, University of Washington, Seattle, Washington
  • Jeffrey M. Peters
    Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland
  • Frank J. Gonzalez
    Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland
  • Jean-Charles Fruchart
    Unit 545, INSERM, Département d’Athérosclérose, Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France
  • Gérard Reach
    Unit 341, INSERM, Hôtel-Dieu, Paris, France
  • Bart Staels
    Unit 545, INSERM, Département d’Athérosclérose, Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France

書誌事項

公開日
2001-12-01
DOI
  • 10.2337/diabetes.50.12.2809
公開者
American Diabetes Association

この論文をさがす

説明

<jats:p>Peroxisome proliferator–activated receptor (PPAR)-α controls the expression of genes involved in lipid metabolism. PPAR-α furthermore participates to maintain blood glucose during acute metabolic stress, as shown in PPAR-α–null mice, which develop severe hypoglycemia when fasted. Here, we assessed a potential role for PPAR-α in glucose homeostasis in response to long-term high-fat feeding. When subjected to this nutritional challenge, PPAR-α–null mice remained normoglycemic and normoinsulinemic, whereas wild-type mice became hyperinsulinemic (190%; P &lt; 0.05) and slightly hyperglycemic (120%; NS). Insulin tolerance tests (ITTs) and glucose tolerance tests (GTTs) were performed to evaluate insulin resistance (IR). Under standard diet, the response to both tests was similar in wild-type and PPAR-α–null mice. Under high-fat diet, however, the efficiency of insulin in ITT was reduced and the amount of hyperglycemia in GTT was increased only in wild-type and not in PPAR-α–null mice. The IR index, calculated as the product of the areas under glucose and insulin curves in GTT, increased fourfold in high-fat–fed wild-type mice, whereas it remained unchanged in PPAR-α–null mice. In contrast, PPAR-α deficiency allowed the twofold rise in adiposity and blood leptin levels elicited by the diet. Thus, the absence of PPAR-α dissociates IR from high-fat diet–induced increase in adiposity. The effects of PPAR-α deficiency on glucose homeostasis seem not to occur via the pancreas, because glucose-stimulated insulin secretion of islets was not influenced by the PPAR-α genotype. These data suggest that PPAR-α plays a role for the development of IR in response to a Western-type high-fat diet.</jats:p>

収録刊行物

  • Diabetes

    Diabetes 50 (12), 2809-2814, 2001-12-01

    American Diabetes Association

被引用文献 (8)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ